Postmortem findings of malignant pleural mesothelioma: A two-center study of 318 patients

Chest

Volumn 142, Issue 5, 2012, Pages 1267-1273

  Finn, Rhian S ^a   Brims, Fraser J H ^b,d   Gandhi, Arjun ^b   Olsen, Nola ^c   Musk, A William ^b,c   Maskell, Nick A ^e   Lee, Y C Gary ^b,c  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; AUTOPSY; BODY MASS; BRAIN METASTASIS; CANCER LOCALIZATION; CAUSE OF DEATH; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG EMBOLISM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SPLEEN METASTASIS; THYROID METASTASIS; UNITED KINGDOM;

EID: 84868611180     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-3204     Document Type: Article

References (29)

1. Driscoll T, Nelson DI, Steenland K, et al. The global burden of disease due to occupational carcinogens. Am J Ind Med. 2005;48(6):419-431. (Pubitemid 41746860)
2. Le GV, Takahashi K, Park EK, et al. Asbestos use and asbestos-related diseases in Asia: past, present and future. Respirology. 2011;16(5):767-775.
3. Brims FJ. Asbestos-a legacy and a persistent problem. J R Nav Med Serv. 2009;95(1):4-11.
4. Cao CQ, Yan TD, Bannon PG, McCaughan BC. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol. 2010;5(10):1692-1703.
5. Van Schil PE, Baas P, Gaafar R, et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J. 2010;36(6):1362-1369.
6. Hasani A, Alvarez JM, Wyatt JM, et al. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia. J Thorac Oncol. 2009;4(8):1010-1016.
7. de Perrot M, Feld R, Cho BC, et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27(9):1413-1418.
8. Griffiths MH, Riddell RJ, Xipell JM. Malignant mesothelioma: a review of 35 cases with diagnosis and prognosis. Pathology. 1980;12(4):591-603. (Pubitemid 11207388)
9. Law MR, Hodson ME, Heard BE. Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax. 1982;37(11):810-815. (Pubitemid 13203893)
10. Yates DH, Corrin B, Stidolph PN, Browne K. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax. 1997;52(6):507-512. (Pubitemid 27298500)
11. Lumb PD, Suvarna SK. Metastasis in pleural mesothelioma. Immunohistochemical markers for disseminated disease. Histopathology. 2004;44(4):345-352. (Pubitemid 38491301)
12. Olsen NJ, Franklin PJ, Reid A, et al. Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation. Med J Aust. 2011;195(5):271-274.
13. Musk AW, Olsen N, Alfonso H, et al. Predicting survival in malignant mesothelioma. Eur Respir J. 2011;38(6):1420-1424.
14. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005;40(2):90-97. (Pubitemid 40417889)
15. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260-271.
16. Roberts GH. Distant visceral metastases in pleural mesothelioma. Br J Dis Chest. 1976;70(4):246-250.
17. Knappmann J. Observations made at post mortem examination in 251 cases of mesothelioma in Hamburg (1958-1968) [in German]. Pneumonologie. 1972;148(1):60-65.
18. Krumhaar D, Lange S, Hartmann C, Anhuth D. Follow-up study of 100 malignant pleural mesotheliomas. Thorac Cardiovasc Surg. 1985;33(5):272-275. (Pubitemid 16228760)
19. Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant mesothelioma of the pleura: review of 123 patients. Cancer. 1982;49(11):2431-2435. (Pubitemid 12122935)
20. Edge JR, Choudhury SL. Malignant mesothelioma of the pleura in Barrow-in-Furness. Thorax. 1978;33(1):26-30.
21. Dorward AJ, Stack BH. Diffuse malignant pleural mesothelioma in Glasgow. Br J Dis Chest. 1981;75(4):397-402. (Pubitemid 11018327)
22. Whitwell F, Rawcliffe RM. Diffuse malignant pleural mesothelioma and asbestos exposure. Thorax. 1971;26(1):6-22.
23. Huncharek M, Muscat J. Metastases in diffuse pleural mesothelioma: influence of histological type. Thorax. 1987;42(11):897-898. (Pubitemid 17160892)
24. Ruffie P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol. 1989;7(8):1157-1168. (Pubitemid 19196542)
25. Hulks G, Thomas JS, Waclawski E. Malignant pleural mesothelioma in western Glasgow 1980-6. Thorax. 1989;44(6):496-500. (Pubitemid 19165809)
26. Alvarez JM, Hasani A, Segal A, et al. Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy. ANZ J Surg. 2009;79(10):734-738.
27. Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma. J Thorac Oncol. 2011;6(5):896-904.
28. Ordóñez NG. Pleomorphic mesothelioma: report of 10 cases. Mod Pathol. 2012;25(7):1011-1022.
29. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg. 2009;15(1):4-9.